Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Non-Current Assets: 2021-2022

Historic Non-Current Assets for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $2.8 million.

  • Milestone Pharmaceuticals' Non-Current Assets rose 179.76% to $2.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.8 million, marking a year-over-year increase of 179.76%. This contributed to the annual value of $926,000 for FY2021, which is N/A change from last year.
  • Per Milestone Pharmaceuticals' latest filing, its Non-Current Assets stood at $2.8 million for Q3 2022, which was up 257.34% from $797,000 recorded in Q2 2022.
  • Milestone Pharmaceuticals' 5-year Non-Current Assets high stood at $2.8 million for Q3 2022, and its period low was $797,000 during Q2 2022.
  • Over the past 2 years, Milestone Pharmaceuticals' median Non-Current Assets value was $1.0 million (recorded in 2021), while the average stood at $1.2 million.
  • Over the last 5 years, Milestone Pharmaceuticals' Non-Current Assets had its largest YoY gain of 179.76% in 2022, and its largest YoY loss of 30.53% in 2022.
  • Over the past 2 years, Milestone Pharmaceuticals' Non-Current Assets (Quarterly) stood at $926,000 in 2021, then spiked by 179.76% to $2.8 million in 2022.
  • Its Non-Current Assets stands at $2.8 million for Q3 2022, versus $797,000 for Q2 2022 and $833,000 for Q1 2022.